Summary
This 2019 Nature Medicine study investigated the genetic basis of visceral adiposity and its causal contribution to cardiovascular and metabolic disease. Using large-scale genetic data, the authors quantified heritability and identified genetic loci associated with visceral fat accumulation, as distinct from general obesity. The findings suggest that genetic predisposition to visceral adiposity represents a measurable independent risk factor for cardiometabolic outcomes.
UK applicability
The genetic findings are likely relevant to UK populations of European ancestry, though direct applicability depends on whether the identified variants show consistent effect sizes across UK biobanks. The work supports precision medicine approaches to identifying individuals at elevated cardiometabolic risk based on genetic profile rather than BMI alone.
Key measures
Heritability estimates for visceral adiposity; genome-wide association study (GWAS) signals; genetic correlation with cardiometabolic traits; mendelian randomisation estimates of causal effect
Outcomes reported
The study examined the genetic architecture of visceral adiposity and its causal relationship to cardiovascular and metabolic disease outcomes. It quantified the heritability of visceral fat distribution and identified genetic variants associated with visceral adiposity independent of overall body mass.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.